STOCK TITAN

PetVivo investor group reports 38.2% stake

A.L. Sarroff Fund and related parties report a 38.2% beneficial stake in PetVivo Holdings, Inc. common stock, including shares issuable upon warrant exercise.

(Moderate)
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

PetVivo Holdings, Inc. (PETV) received an amended Schedule 13D (Amendment No. 2) from A.L. Sarroff Fund, LLC, Alan Sarroff, and Eileen Sarroff reporting their beneficial ownership of the company’s common stock.

The reporting group states beneficial ownership of 16,940,839 shares of common stock, representing 38.2% of the class, based on 37,950,495 shares outstanding as of August 14, 2026 and assuming the exercise of warrants for 6,442,508 shares. They acquired their position for investment through open market purchases and private placements using personal funds, and indicate they may increase or decrease their economic exposure over time, including through derivatives, while currently disclosing no specific plans regarding corporate actions listed in the Schedule 13D items.

Positive

  • None.

Negative

  • None.

Filing Explained

The Sarroff reporting group reports 16,940,839 shares under shared voting and dispositive power, with no sole power reported; its 38.2% beneficial-ownership figure is based on 37,950,495 shares outstanding as of August 14, 2026 and assumes exercise of 6,442,508 warrants.

Beneficial ownership 16,940,839 shares Aggregate PetVivo common shares beneficially owned by the reporting persons
Ownership percentage 38.2% Portion of PetVivo common stock represented by the reporting persons’ beneficial ownership
Shares outstanding 37,950,495 shares PetVivo common shares outstanding as of August 14, 2026 used in the ownership calculation
Warrants assumed in calculation 6,442,508 shares Shares of PetVivo common stock issuable upon exercise of warrants assumed in beneficial ownership
Event date September 14, 2026 Date of the event requiring the Schedule 13D/A filing
Joint Filing Agreement date January 16, 2026 Date the reporting persons entered into their Joint Filing Agreement
beneficial ownership financial
"The Reporting Persons beneficially own an aggregate of 16,940,839 shares of common stock"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Schedule 13D regulatory
"This is filed by A.L. Sarroff Fund, LLC ... with respect to the shares"
A Schedule 13D is a legal document that investors file with regulators when they buy a large enough stake in a company to potentially influence its management or decisions. It provides details about the investor’s intention, ownership stake, and plans, helping other investors understand who is gaining control and what their motives might be.
security-based swaps financial
"including any class of the Issuer's securities used as a reference security, in connection with any of the following: call options, put options, security-based swaps"
Joint Filing Agreement regulatory
"On January 16, 2026, the Reporting Persons entered into a Joint Filing Agreement"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What ownership stake in PETV does A.L. Sarroff Fund report in this Schedule 13D/A?

The reporting persons disclose beneficial ownership of 16,940,839 shares of PetVivo Holdings, Inc. common stock, representing 38.2% of the outstanding class, based on 37,950,495 shares outstanding as of August 14, 2026 and assuming exercise of certain warrants.

How many PetVivo (PETV) shares are used as the basis for the 38.2% ownership calculation?

The 38.2% ownership figure is based on 37,950,495 shares of common stock outstanding as of August 14, 2026, and assumes the exercise of warrants to purchase 6,442,508 shares of PetVivo common stock.

Who are the reporting persons in this PetVivo (PETV) Schedule 13D/A filing?

The filing is made jointly by A.L. Sarroff Fund, LLC, Alan Sarroff, and Eileen Sarroff. The fund is a New York limited liability company; Alan Sarroff is its Chief Executive Officer and Managing Member, and both Alan and Eileen are U.S. citizens.

How did the Sarroff group acquire its investment in PetVivo (PETV)?

The reporting persons state that they acquired their PetVivo securities for investment purposes through open market purchases and private placements in PetVivo Holdings, Inc., using personal funds.

Does the Sarroff group indicate plans to change its PetVivo (PETV) position?

They state they will continue to review their investment and may increase or decrease their position or economic exposure, including via derivatives, depending on factors such as PetVivo’s financial position and market conditions, while stating no specific plans regarding the enumerated corporate actions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





716817408

(CUSIP Number)
Jeffrey J. Fessler, Esq.
30 Rockefeller Plaza,
New York, NY, 10112
(212) 653-8700

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
09/14/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


A.L. Sarroff Fund, LLC
Signature:/s/ Alan Sarroff
Name/Title:By Alan Sarroff, Chief Executive Officer and Managing Member
Date:09/15/2026
Alan Sarroff
Signature:/s/ Alan Sarroff
Name/Title:Alan Sarroff
Date:09/15/2026
Eileen Sarroff
Signature:/s/ Eileen Sarroff
Name/Title:Eileen Sarroff
Date:09/15/2026

Keep reading